ArticleExploration of targeted anti-tumor therapy2022

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer.

Samuel Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.